Daiichi licenses Japanese rights to Kite's CART candidate axicabtagene ciloleucel
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Royalty or Profit Split Information
- R+D and Marketing-Licensing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.